Mitochondrial function as a therapeutic target in heart failure
David A. Brown, Mihai Gheorghiade(Northwestern University), Stephen J. Greene(Duke University), Burkert Pieske(German Centre for Cardiovascular Research), John G.F. Cleland(Imperial College London), Gerasimos Filippatos(National and Kapodistrian University of Athens), Saame Raza Shaikh(East Carolina University), Wilson S. Colucci(Cornell University), Justin B. Perry(Virginia Tech), Adriaan A. Voors, Javed Butler(Emory University), Brian L. Stauffer(University of Colorado Denver), Hani N. Sabbah(Henry Ford Hospital), Bertram Pitt(University of Michigan–Ann Arbor), Mitchell E. Allen(Virginia Tech), Stefan D. Anker(German Centre for Cardiovascular Research)
Cited by 786
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k